Home/AlphaRose Therapeutics/Robert Cabrera, PhD
RC

Robert Cabrera, PhD

Chief Science Officer

AlphaRose Therapeutics

AlphaRose Therapeutics Pipeline

DrugIndicationPhase
Undisclosed PipelineRare Genetic Diseases (Pediatric Focus)Pre-clinical